SHP2 Inhibitor ET0038 Monotherapy in Patients With Advanced Solid Tumors

Clinical trial NCT05525559 · UNKNOWN

Trial details

NCT number: NCT05525559
Sponsor: Etern BioPharma (Shanghai) Co., Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2022-11-01
Primary completion: 2024-11-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.